- Home
- FUSB vs PDSB Comparison
FUSB vs PDSB Comparison
Compare FUSB & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- PDSB
- Stock Information
- Founded
- FUSB 1952
- PDSB 2005
- Country
- FUSB United States
- PDSB United States
- Employees
- FUSB N/A
- PDSB N/A
- Industry
- FUSB Major Banks
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- FUSB Finance
- PDSB Health Care
- Exchange
- FUSB Nasdaq
- PDSB Nasdaq
- Market Cap
- FUSB 73.3M
- PDSB 84.2M
- IPO Year
- FUSB N/A
- PDSB N/A
- Fundamental
- Price
- FUSB $12.99
- PDSB $1.49
- Analyst Decision
- FUSB
- PDSB Strong Buy
- Analyst Count
- FUSB 0
- PDSB 3
- Target Price
- FUSB N/A
- PDSB $14.00
- AVG Volume (30 Days)
- FUSB 2.0K
- PDSB 279.8K
- Earning Date
- FUSB 01-31-2025
- PDSB 11-14-2024
- Dividend Yield
- FUSB 1.74%
- PDSB N/A
- EPS Growth
- FUSB 5.90
- PDSB N/A
- EPS
- FUSB 1.40
- PDSB N/A
- Revenue
- FUSB $40,310,000.00
- PDSB N/A
- Revenue This Year
- FUSB N/A
- PDSB N/A
- Revenue Next Year
- FUSB N/A
- PDSB N/A
- P/E Ratio
- FUSB $8.81
- PDSB N/A
- Revenue Growth
- FUSB 0.79
- PDSB N/A
- 52 Week Low
- FUSB $8.66
- PDSB $1.30
- 52 Week High
- FUSB $14.30
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- FUSB 50.96
- PDSB 37.02
- Support Level
- FUSB $12.34
- PDSB $1.37
- Resistance Level
- FUSB $13.00
- PDSB $1.50
- Average True Range (ATR)
- FUSB 0.48
- PDSB 0.13
- MACD
- FUSB -0.01
- PDSB 0.01
- Stochastic Oscillator
- FUSB 87.27
- PDSB 35.61
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.